Evofem Biosciences, Inc. (NASDAQ:EVFM – Get Free Report)’s share price crossed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $0.01 and traded as high as $0.01. Evofem Biosciences shares last traded at $0.01, with a volume of 172,262 shares traded.
Evofem Biosciences Stock Down 4.3 %
The company’s fifty day moving average is $0.01 and its two-hundred day moving average is $0.01. The stock has a market cap of $1.02 million, a price-to-earnings ratio of -0.01 and a beta of -0.74.
About Evofem Biosciences
Evofem Biosciences, Inc, a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women, and EVO200 for the prevention of recurrent bacterial vaginosis.
Recommended Stories
- Five stocks we like better than Evofem Biosciences
- 3 Fintech Stocks With Good 2021 Prospects
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- What is MarketRank™? How to Use it
- The 3 Most Talked About Investments on WallStreetBets Right Now
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for Evofem Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evofem Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
